Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix

NCT06810895 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Ding Ma